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CASE REPORT
Complete regression of primary 
cutaneous malignant melanoma associated 
with distant lymph node metastasis: a teaching 
case mimicking blue nevus
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Abstract 
Background: Malignant melanoma (MM) tends to be spontaneously regressed, however, complete regression of 
primary cutaneous MM is an extremely rare phenomenon. Our aim is to be aware that pathologists and/or dermatolo-
gists can readily misinterpret it as the other benign or malignant lesions.
Case presentation: A gradually growing and verrucous hypopigmented macule had been noticed in the right sole 
of a 65-year-old Japanese male since 2 years before, and it turned to be a solitary bluish to black patch with sur-
rounding depigmentation and was recently decreased in size. In parallel, the patient had a rapidly growing black-
pigmented mass lesion at the right inguen. The cutaneous specimen from the sole showed an aggregation of many 
melanophages predominantly in the middle to deep layer of dermis, associated with surrounding fibrosis, reactive 
vascular proliferation and CD8-positive T-lymphocytic infiltrate, covered by attenuated epidermis with absence of rete 
ridge. However, no remnant MM cells were completely seen in the step-serial sections. We first interpreted it as blue 
nevus. By contrast, the inguinal mass revealed a diffuse proliferation of highly atypical mono- to multi-nucleated large 
cells having abundant eosinophilic cytoplasm in the enlarged lymph node tissue. Immunohistochemical findings 
demonstrated that these atypical cells were specifically positive for HMB45 and Melan A. Therefore, we finally made a 
diagnosis of complete regression of primary cutaneous MM associated with distant lymph node metastasis of MM.
Conclusion: Careful, not only general/cutaneous but histopathological, examinations should be necessary and 
adjunctive aids for reaching the correct diagnosis of complete regression of cutaneous MM.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Among all malignant melanomas (MMs), partial regres-
sion is not uncommon, accounting for 10 to 35 % regard-
less of Breslow’s tumor thickness [1, 2]. In particular, 
thin MMs, less than 1  mm thickness, reportedly show 
partial regression in up to 61  % of all tumor lesions [2, 
3]. By contrast, complete regression of primary cutane-
ous MM is a much rarer occurrence with merely 0.24 % 
in 2464 MM patients [4], and only 39 cases have been 
reported in the English-language literature, to the best 
of our knowledge [2]. Smith and Stehlin [5] have already 
established criteria for complete regression of MM as fol-
lows: (a) history and/or clinical evidence of a pigmented 
lesion situated in an area drained by tumor-involved 
lymph nodes; (b) absence of any other primary lesions 
identifiable by history or physical examination that could 
represent the origin of MM; (c) presence of atypical pig-
mented or depigmented change in the skin at the site 
of the untreated presumed primary lesion, with all or a 
majority of the typical histologic features associated with 
regression found on biopsy (attenuated epidermis, der-
mal melanophages, lymphocytic or chronic inflammatory 
Open Access
BMC Research Notes
*Correspondence:  sohsuke@m.kufm.kagoshima-u.ac.jp 
1 Department of Pathology, Field of Oncology, Kagoshima University 
Graduate School of Medical and Dental Sciences, Kagoshima, Japan
Full list of author information is available at the end of the article
Page 2 of 6Yamada et al. BMC Res Notes  (2016) 9:366 
infiltrate, reactive vascular proliferation, and fibrosis); 
and (d) Histologic absence of MM cells in excised lesions 
(step-serial sections of the entire primary site are impor-
tant to confirm the absence of small residual foci of 
malignant cells) [5, 6]. Clinically, complete regression of 
MM is characterized by variability with a ‘change’, mani-
festing as hyper- to hypo-pigmented macules, patches, 
papules, and plaques, measuring from 0.4 to 3.0  cm 
in diameter, and most commonly displaying enlarge-
ment, friability, bleeding, and eventual regression [2]. 
These changes have a tendency to occur from 2 months 
to 14  years before the diagnosis of metastatic MM [2]. 
Moreover, it has been reported that the patients’ progno-
ses are highly variable, ranging from 6 weeks to 11 years 
after its diagnosis, whereas 13 patients actually died of 
MM progression with an average survival of 13 months 
[2, 5, 6]. Thus, it is critical to establish an accurate initial 
diagnosis, including whether associated metastatic MM 
sites or not in the whole body by thorough clinicopatho-
logical examinations.
We report an extremely rare case of complete regres-
sion of primary cutaneous MM coexisted with distant 
lymph node metastasis, possibly confused with other 
benign or malignant lesions of the skin.
Case presentation
Methods
The patient was a 65-year-old Japanese man. The cutane-
ous and inguinal specimens after fixation in 10 % neutral 
buffered formalin were embedded in paraffin for his-
tological or immunohistochemical examinations. Fur-
thermore, we prepared more than 10 step-serial H&E 
staining sections of the entire primary site (right sole), 
and absolutely confirmed the absence of residual foci of 
MM cells [2, 5, 6]. All immunohistochemical stainings 
were carried out using Dako Envision kit (Dako Cytoma-
tion Co., Glostrup, Denmark) according to the manufac-
turer’s instructions. [7–11]. We counted the numbers of 
CD4 (Dako, diluted 1:1)—and CD8 (Nichirei Biosciences 
Inc., Tokyo, Japan, diluted 1:1)—positive infiltrating 
T-lymphocytes in the cutaneous pigmented lesion (right 
sole) in 10 randomly selected fields of per section (origi-
nal magnification: ×400) [7–11].
All histological and immunohistochemical slides were 
evaluated by two independent observers (certified surgi-
cal pathologists in our department) [7–11]. Agreement 
between observers was excellent (>0.9) for all antibodies 
investigated as measured by interclass correlation coeffi-
cient. For the few instances of disagreements, a consen-
sus score was determined by the third board-certified 
pathologists in our department [7–11]. All values are 
expressed as the mean ± SE. Significant differences were 
analyzed using Student’s t test. Values of P  <  0.05 were 
considered to be statistically significant.
Clinical summary
The patient had an unremarkable previous medical his-
tory, except for essential hypertension. The patient was 
admitted to hospital due to an approximately 2-months 
history of inguinal growing mass and pain. There had 
been no history of malignancy, immunosuppressive dis-
orders, use of immunosuppressive medications, or unu-
sual infections, including acquired immunodeficiency 
syndrome (AIDS).
He had noticed a gradually growing, hemorrhagic and 
verrucous hypopigmented macule since approximately 
2  years before, and it turned to be a solitary bluish to 
black patch with surrounding depigmentation, accompa-
nied by recent decrease in size, measuring up to 20 mm in 
the right sole (Fig. 1a). There were no other primary cuta-
neous lesions identifiable by his history or careful physi-
cal examination that could represent the original MM. In 
parallel, he suffered from a rapidly growing and painful 
black-pigmented mass lesion with surface skin ulcer at 
the right inguen especially for recent 2 months (Fig. 1b), 
partly extending to the right scrotum and thigh (Fig. 1b). 
A pelvic CT scan showed a relatively well-defined huge 
and low-density mass with peripheral enhancement, 
measuring approximately 12 × 10 cm (Fig. 1c). CT scans 
of the head, neck, chest and abdomen disclosed no defi-
nite evidence of neoplastic foci or other metastases in the 
lymph nodes or other organs. Laboratory data, includ-
ing blood cell count, chemistry and tumor markers, were 
within normal limits. Within the post-operative 2  years 
with additional treatment of chemotherapy, including 
dacarbazine, nimustine, cisplatin, tamoxifen, (DAC-tam) 
and interferon-β, recurrence of small (less than 5  mm) 
MMs in situ was noted in the right foot, waist and back at 
1 month after the operation. But, surprisingly, the patient 
had neither local invasion nor metastases of the other 
sites, respectively, and he was alive and well.
Pathological findings
The surgical cutaneous specimen from the right sole 
(Fig. 2a) showed a hyperpigmented lesion made up of an 
aggregation of melanophages with surrounding variably 
sclerotic fibrosis mainly in the middle to deep layer of der-
mis. On high-power view, these aggregated round to oval 
cells had bland-looking small nuclei and abundant mela-
nin-pigmented cytoplasm (Fig.  2b). In addition, reactive 
vascular networks were occasionally seen in these fibrous 
stroma, associated with mild interstitial and perivascular 
lymphocytic infiltrate (Fig.  2c). The covering non-disor-
dered epidermis exhibited attenuated and atrophic change 
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with absence of rete ridge, carrying no in  situ MM cells 
within our thorough examination (Fig.  2a, c). Interest-
ingly, the peripheral epidermis sometimes showed exocy-
tosis of focal nested lymphocytes (Fig. 2c). Nevertheless, 
there was no MM cells infiltration from the epidermis to 
dermis, subcutis in all of the prepared step-serial H&E 
staining sections. Based on these features, we first diag-
nosed it as a benign cutaneous lesion, such as blue nevus. 
Immunohistochemically, these melanophages were 
strongly positive for CD68 (KP-1; Dako, diluted 1:100) 
(Fig.  2b), whereas completely negative for S-100 protein 
(Dako, diluted 1:900), HMB45 (Enzo Life Sciences Ltd., 
New York, diluted 1:100), and Melan A (NOVOCASTRA, 
1:50) (data not shown). Furthermore, we counted the 
numbers of CD4- and CD8-positive infiltrating T-lym-
phocytes in this cutaneous lesion (Fig.  2d). Intriguingly, 
CD8-positive T-lymphocytes were markedly larger than 
CD4-positive lymphocytes in number (CD4: 1.8 ± 0.5 per 
1 high power field vs. CD8: 54.6 ± 5.2 per 1 high power 
field; P < 0.0001) (Fig. 2d).
Next, gross examination of the surgical specimen from 
the inguinal to scrotal and femoral mass showed that 
the huge, relatively well-demarcated and multi-nodular 
tumor, measuring approximately 13  ×  11  ×  7  cm, had 
gray-whitish to yellow-whitish cut surfaces with hem-
orrhagic and yellowish necrotic foci (Fig.  3a). Micro-
scopically, the inguinal tumor consisted of a diffuse 
proliferation of markedly atypical large cells (Fig. 3b) hav-
ing hyperchromatic, pleomorphic mono- to multi-nuclei, 
and abundant eosinophilic to sometimes clear cyto-
plasm, appearing predominantly as single cells, admixed 
with a large number of likely pre-existing lymphocytes 
(Fig.  3c). These proliferating tumor cells involved and 
erased the remarkably enlarged lymph node tissue, partly 
surrounded by fibrous capsule (Fig. 3b). On high-power 
view, the large tumor cells occasionally had melanin pig-
ments in the cytoplasm and often showed autophagy 
(Fig. 3c). In immunohistochemistry, these malignant cells 
were specifically positive for melanocytic markers, such 
as HMB45 (Fig.  3d) and Melan A (Fig.  3d), and S-100 
a b
c
Fig. 1 Macroscopic and imaging findings of this complete regression of cutaneous MM on the right sole associated with right inguinal lymph 
node metastasis. a, b The patient had a solitary bluish to black patch with surrounding depigmentation, accompanied by recent decrease in size, 
measuring up to 20 mm in the right sole. In fact, he had noticed it as a gradually growing, hemorrhagic and verrucous hypopigmented macule since 
approximately 2 years before. Bar  2 cm. b In parallel, he suffered from a rapidly growing and painful black-pigmented mass lesion with surface skin 
ulcer at the right inguen especially for recent 2 months, partly extending to the right scrotum and thigh. Bar  5 cm. c A pelvic CT scan revealed a 
relatively well-defined huge and low-density mass with peripheral enhancement, measuring approximately 10 × 8 cm. Bar  5 cm
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protein (data not shown), whereas negative for CD68 
(data not shown).
Based on all the clinicopathological features, we con-
firmed that these proliferating atypical cells were derived 
from MM, and finally made a diagnosis of complete 
regression of primary cutaneous MM on the right sole, 
associated with distant inguinal lymph node metastasis 
of MM.
Conclusion
The most important histological differential diagnosis 
in the present completely regressed MM case is with a 
remnant MM of the skin. Immunohistochemical analyses 
would be able to resolve the distinction from the malig-
nancy easily, because the highly atypical MM cells were 
specifically positive for melanoma-associated antigens, 
representing as HMB45 and Melan A, whereas com-
pletely negative for histiocytic markers, such as CD68, 
but in striking contrast, the bland-looking melanophages 
were not, as shown in the current report. Moreover, as 
previously indicated by Smith and Stehlin [5], after we 
have prepared more than 10 step-serial H&E-stained sec-
tions of the entire primary site from the right sole, we can 
completely confirm the absence of residual foci of the 
MMs. Besides, our case actually fitted the clinicopatho-
logical categories for complete regression of MM as fol-
lows: (i) history and clinical evidence of this pigmented 
lesion on the right sole situated in an area drained by 
the MM-involved right inguinal lymph nodes; (ii) com-
plete absence of any other primary lesions identifiable 
by history or physical examinations that could represent 
the original sites of MM; (c) presence of variable pig-
mented and/or depigmented change in the right sole, as 
the untreated primary cutaneous lesion, accompanied by 
all of the typical, histopathologically regressed features, 
including attenuated atrophic epidermis, dermal aggrega-
tion of many melanophages, lymphocytic infiltrate, reac-




Fig. 2 Microscopic examination of the complete regression of primary cutaneous MM. a On low-power view of the surgical cutaneous specimen 
from the right sole, a hyperpigmented lesion was made up of an aggregation of melanophages with surrounding variably sclerotic fibrosis mainly in 
the middle to deep layer of dermis (H&E stains). The covering non-disordered epidermis exhibited attenuated and atrophic change with absence of 
rete ridge. Bar  2 mm. b On high-power view (H&E stains), these aggregated round to oval cells contained bland-looking small nuclei and abundant 
melanin-pigmented cytoplasm. In addition, immunohistochemically, these melanophages were strongly positive for CD68 (inset). Bar  50 μm. c In 
these fibrotic dermis, reactive vascular networks were noted, associated with mild interstitial and perivascular lymphocytic infiltrate. Furthermore 
the peripheral epidermis displayed exocytosis of focal nested lymphocytes (inset). Bar  500 μm. d In immunohistochemistry, dermal infiltrating CD8-
positive T-lymphocytes (right) were markedly larger than CD4-positive T-lymphocytes (left) in number in this cutaneous lesion. Bar  1000 μm
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5, 6]. On the other hand, among benign lesions, patho-
logical differential diagnoses would include blue nevus 
or scar, since complete regression of cutaneous MM and 
each benign lesion can share variable histological fea-
tures, as described here. Despite that, we pathologists 
and/or dermatologists should be aware that thorough 
and adequate clinicopathological examinations can 
readily distinguish from the above malignant to benign 
diagnoses.
As to the present case, it is clinicopathologically 
remarkable for two reasons at least: first, within our 
thorough investigation, this is the first single-case report 
of complete regression of cutaneous MM arising in the 
sole, clinicopathologically mimicking blue nevus, due 
to histologically middle to deep dermal melanophages 
at least in part. Indeed, to date, the papers reported as 
completely regressed MM have been very rarely pub-
lished in the English literatures, but the number of its 
‘true’ cases remain unclear, because metastatic MM of 
unknown primary origin accounts for approximately 2.5 
to 10  % among all presenting MMs, according to most 
large series of MM [2, 12]. Furthermore, it is very likely 
that most cases of undetected primary cutaneous MMs 
undergo near-complete regression prior to metastatic 
involvement and progression [12]. In that sense, it is sug-
gested that complete regression of primary cutaneous 
MM might be much more common than generally con-
sidered. Second, the present primary site surrounded by 
the variable fibrosis and vascular networks contained 
a dermal infiltration of much more predominant CD8-
positive T-lymphocytes than CD4-positive ones, as 
shown in Fig. 2d. According to one possible theory, ‘anti-
tumor immune response’, explaining the MM regression 
mechanism(s) [12, 13], MM cells can express specific 
antigens, including Melan A (MART-1), identified by the 
distinct immune systems of each MM patient. Subse-
quently, MM patients can generate spontaneous immune 
responses to a wide range of these MM-specific antigens, 
HMB45 Melan Adc
ba
Fig. 3 Gross and microscopic examination of the metastatic lymph node metastasis. a On gross findings of the surgical specimen from the inguinal 
to scrotal and femoral mass, the huge, relatively well-demarcated and multi-nodular tumor, measuring approximately 8 × 6 cm, showed gray-
whitish to yellow-whitish cut surfaces with hemorrhagic and yellowish necrotic foci. Bar  1 cm. b Microscopically, this inguinal tumor consisted of a 
diffuse proliferation of markedly atypical large cells, appearing predominantly as single cells (inset), involving and erasing the remarkably enlarged 
pre-existing lymph node tissue, partly surrounded by fibrous capsule (arrows). Bar  1000 μm. c On high-power view, these tumor cells contained 
hyperchromatic, pleomorphic mono- to multi-nuclei, and abundant eosinophilic to sometimes clear cytoplasm, admixed with a number of 
lymphocytes. Additionally, the large tumor cells occasionally had melanin pigments in the cytoplasm (left) and often showed autophagy (right). 
Bar  50 μm. d In immunohistochemistry, these malignant cells were specifically positive for melanocytic markers, such as HMB45 (left) and Melan A 
(right). Bar  100 μm
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via tumor-infiltrating lymphocytes (TILs), especially 
CD4- and CD8-positive T-lymphocytes [14]. In particu-
lar, it is possible that the cell-mediated cytotoxicity of 
CD8-positive T-lymphocytes infiltrate can serve as an 
early sign of MM regression, similar to the patients with 
halo nevi, as previously demonstrated [2, 15]. Neverthe-
less, future convincing data will be further required to 
determine whether our speculation is significant or not.
We reported an extremely rare case of complete regres-
sion of primary cutaneous MM associated with distant 
lymph node metastasis of MM, dermatopathologically 
mimicking blue nevus at the primary site of MM. All 
pathologists and dermatologists should be aware that its 
characteristic features could easily lead to a misdiagnosis 
of the other benign or malignant lesions. Furthermore, it 
is suggested that we pathologists and/or dermatologists 
should be aware that thorough and adequate clinico-
pathological analyses, including careful general/cutane-
ous examinations and step-serial H&E staining sections 
of the entire primary site, are very useful and adjunctive 
aids for recognizing no evidence of malignancy (i.e., no 
residual MM cells) and reaching the correct diagnosis 
of completely regressed cutaneous MM associated with 
metastatic foci. In this context, the present case report 
should interest the scientific community, taken together 
with new histopathological findings and specific recom-
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